Com a compra da irlandesa Covidien, em 2015, a empresa inclusive mudou sua sede para a Irlanda.
Medtronic to buy Covidien for $42.9 billion, rebase in Ireland
(Reuters) - U.S. medical device maker Medtronic Inc (MDT.N) said on Sunday it had agreed to buy Covidien Plc COV.N for $42.9 billion in cash and stock and move its executive base to Ireland in the latest transaction aiming for lower corporate tax rates abroad.
“The real purpose of this, in the end, is strategic, both in the intermediate term and the long term,” Medtronic Chief Executive Omar Ishrak said in an interview after the deal was announced. “It is good for the U.S. in that we will make more investment in U.S. technologies, which previously we could not.”
Medtronic to buy Covidien for $42.9 billion, rebase in Ireland | Reuters